<SEC-DOCUMENT>0001140361-17-041378-index.html : 20171107
<SEC-HEADER>0001140361-17-041378.hdr.sgml : 20171107
<ACCEPTANCE-DATETIME>20171107160708
ACCESSION NUMBER:		0001140361-17-041378
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20171103
FILED AS OF DATE:		20171107
DATE AS OF CHANGE:		20171107

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Abdun-Nabi Daniel
		CENTRAL INDEX KEY:			0001380187

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33137
		FILM NUMBER:		171183434

	MAIL ADDRESS:	
		STREET 1:		400 PROFESSIONAL DRIVE
		STREET 2:		SUITE 400
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20879

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Emergent BioSolutions Inc.
		CENTRAL INDEX KEY:			0001367644
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				141902018
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		400 PROFESSIONAL DR, SUITE 400
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20879
		BUSINESS PHONE:		240-631-3200

	MAIL ADDRESS:	
		STREET 1:		400 PROFESSIONAL DR, SUITE 400
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20879
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc1.xml
<DESCRIPTION>FORM 4
<TEXT>
Document 1 - file: doc1.html

Document 1 - RAW XML: doc1.xml

</DOCUMENT>
</SEC-DOCUMENT>